Tina Vilsbøll

Tina Vilsbøll

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. 1994
  2. Published

    Intrauterin insemination med donorsaed. Behandling af ufrivillig barnløshed på grund af mandlig infertilitet

    Vilsbøll, Tina, Helmsøe-Zinck, L. & Andersen, A. N., 22 Aug 1994, In: Ugeskrift for Laeger. 156, 34, p. 4826-9 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 1995
  4. Published

    Homolog intrauterin insemination som basisbehandling af infertile par

    Helmsøe-Zinck, L., Vilsbøll, Tina & Andersen, A. N., 9 Jan 1995, In: Ugeskrift for Laeger. 157, 2, p. 173-5 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. 2000
  6. Published

    Evaluation of beta-cell secretory capacity using glucagon-like peptide 1

    Vilsbøll, Tina, Nielsen, M. T., Krarup, T., Madsbad, Sten, Dinesen, B. I. & Holst, J. M., 1 Jun 2000, In: Diabetes Care. 23, 6, p. 807-12 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. 2001
  8. Published

    No reactive hypoglycaemia in type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose

    Vilsbøll, Tina, Krarup, T., Madsbad, Sten & Holst, Jens Juul, 1 Feb 2001, In: Diabetic Medicine. 18, 2, p. 144-149 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients

    Vilsbøll, Tina, Krarup, T., Deacon, C. F., Madsbad, Sten & Holst, J. M., 1 Mar 2001, In: Diabetes. 50, 3, p. 609-613 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. 2002
  11. Published

    19th Anglo-Danish-Dutch Diabetes Group meeting

    de Koning, E. J. P., Vilsboll, T., Dela, F. & Vilsbøll, Tina, 1 Mar 2002, In: Diabetic Medicine. 19, 3, p. 259

    Research output: Contribution to journalConference articleResearchpeer-review

  12. Published

    Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients

    Vilsbøll, Tina, Krarup, T., Madsbad, Sten & Holst, J. M., 1 Aug 2002, In: Diabetologia. 45, 8, p. 1111-9 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. 2003
  14. Published

    No hypoglycemia after subcutaneous administration of glucagon-like peptide-1 in lean type 2 diabetic patients and in patients with diabetes secondary to chronic pancreatitis.

    Knop, Filip Krag, Vilsbøll, Tina, Larsen, S., Madsbad, Sten, Holst, J. J. & Krarup, T., 2003, In: Diabetes Care. 26, 9, p. 2581-7 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects

    Vilsbøll, Tina, Agersø, H., Krarup, T. & Holst, J. M., 1 Jan 2003, In: Journal of Clinical Endocrinology and Metabolism. 88, 1, p. 220-4 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. Published

    Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus

    Vilsbøll, Tina, Krarup, T., Sonne, J., Madsbad, Sten, Vølund, A., Juul, Anders, Holst, J. M. & Juul, A. G., 1 Jun 2003, In: Journal of Clinical Endocrinology and Metabolism. 88, 6, p. 2706-13 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  17. Published

    Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects

    Vilsbøll, Tina, Krarup, T., Madsbad, Sten & Holst, J. J., 15 Jul 2003, In: Regulatory Peptides. 114, 2-3, p. 115-121 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype

    Vilsbøll, Tina, Knop, Filip Krag, Krarup, T., Johansen, A., Madsbad, Sten, Larsen, S., Hansen, T., Pedersen, O., Holst, J. M. & Johansen, A., 1 Oct 2003, In: Journal of Clinical Endocrinology and Metabolism. 88, 10, p. 4897-903 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published

    Role of gastrointestinal hormones in postprandial reduction of bone resorption

    Henriksen, D. B., Alexandersen, P., Bjarnason, N. H., Vilsbøll, Tina, Hartmann, B., Henriksen, E. E. G., Byrjalsen, I., Krarup, T., Holst, Jens Juul & Christiansen, C., 1 Dec 2003, In: J Bone Miner Res. 18, 12, p. 2180-2190 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. 2004
  21. Published

    Incretins, insulin secretion and Type 2 diabetes mellitus

    Vilsbøll, Tina & Holst, J. M., 1 Mar 2004, In: Diabetologia. 47, 3, p. 357-66 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    Typical Danish Caucasian type 2 diabetic patients do not commonly carry genetic variants in GIP and GLP-1 encoding regions of the proGIP and proglucagon genes

    Ørskov, C., Hjorth, S. A., Jensen, A. & Vilsbøll, Tina, 15 Jul 2004, In: Regulatory Peptides. 119, 3, p. 151-4 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    On the role of the incretin hormones GIP and GLP-1 in the pathogenesis of Type 2 diabetes mellitus

    Vilsbøll, Tina, 1 Nov 2004, In: Danish Medical Bulletin (Online). 51, 4, p. 364-70 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. 2005
  25. Published

    Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight

    Schou, J. H., Pilgaard, K., Vilsbøll, Tina, Jensen, C. B., Deacon, Carolyn F., Holst, Jens Juul, Vølund, A., Madsbad, Sten & Vaag, Allan, 2005, In: Journal of Clinical Endocrinology and Metabolism. 90, 8, p. 4912-19 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. 2006
  27. Published

    Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution.

    Knop, F. K., Vilsbøll, Tina, Larsen, S., Højberg, P. V., Vølund, A., Madsbad, Sten, Holst, Jens Juul & Krarup, T., 2006, In: American Journal of Physiology: Endocrinology and Metabolism. 292, 1, p. E324-30

    Research output: Contribution to journalJournal articleResearchpeer-review

  28. Published

    The elimination rates of intact GIP as well as its primary metabolite, GIP 3-42, are similar in type 2 diabetic patients and healthy subjects.

    Vilsbøll, Tina, Agersø, H., Lauritsen, T., Deacon, Carolyn F., Aaboe, K., Madsbad, Sten, Krarup, T. & Holst, Jens Juul, 2006, In: Regulatory Peptides. 137, 3, p. 168-72 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  29. Published

    Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake

    Ryskjaer, J., Deacon, Carolyn F., Carr, R. D., Krarup, T., Madsbad, Sten, Holst, Jens Juul, Vilsbøll, Tina, Ryskjaer, J., Deacon, C. F., Carr, R. D., Krarup, T., Madsbad, Sten, Holst, J. J. & Vilsbøll, T., 1 Sep 2006, In: European Journal of Endocrinology. 155, 3, p. 485-93 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  30. 2007
  31. Published

    Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus

    Cypryk, K., Vilsbøll, Tina, Nadel, I., Smyczynska, J., Holst, Jens Juul & Lewinski, A., 2007, In: Gynecological Endocrinology. 23, 1, p. 58-62 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  32. Published

    Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state?

    Knop, F. K., Vilsbøll, Tina, Højberg, P. V., Larsen, S., Madsbad, Sten, Vølund, A., Holst, Jens Juul & Krarup, T., 2007, In: Diabetes. 56, 8, p. 1951-9 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  33. Published

    The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance.

    Knop, F. K., Vilsbøll, Tina, Højberg, P. V., Larsen, S., Madsbad, Sten, Holst, Jens Juul & Krarup, T., 2007, In: Regulatory Peptides. 144, 1-3, p. 123-30 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  34. Published

    Liraglutide: a once-daily GLP-1 analogue for the treatment of type 2 diabetes mellitus

    Vilsbøll, Tina, 1 Feb 2007, In: Expert Opinion on Investigational Drugs. 16, 2, p. 231-7 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  35. Published

    Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus

    Knop, F. K., Vilsbøll, Tina, Madsbad, Sten, Holst, Jens Juul, Krarup, T., Knop, Filip Krag, Vilsbøll, Tina, Madsbad, Sten, Holst, J. M. & Krarup, T., 1 Apr 2007, In: Diabetologia. 50, 4, p. 797-805 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  36. Published

    Betydningen af inkretinhormonerne glucose-dependent insulinotropic peptide og glucagon-like peptide-1 for patogenesen ved type 2-diabetes mellitus

    Vilsbøll, Tina & Knop, Filip Krag, 28 May 2007, In: Ugeskrift for Laeger. 169, 22, p. 2101-5 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  37. Published

    Glucagon-like peptide 1-baseret behandling af type 2-diabetes mellitus

    Knop, Filip Krag & Vilsbøll, Tina, 28 May 2007, In: Ugeskrift for Laeger. 169, 22, p. 2095-9 5 p.

    Research output: Contribution to journalReviewResearchpeer-review

  38. Published

    Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes

    Vilsbøll, Tina, Zdravkovic, M., Le-Thi, T., Krarup, T., Schmitz, O., Courrèges, J., Verhoeven, R., Bugánová, I. & Madsbad, Sten, 1 Jun 2007, In: Diabetes Care. 30, 6, p. 1608-10 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  39. 2008
  40. Published

    Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes

    Højberg, P. V., Vilsbøll, Tina, Rabøl, R., Knop, Filip Krag, Bache, M., Krarup, T., Holst, Jens Juul & Madsbad, Sten, 2008, In: Diabetologia. 52, 2, p. 199-207 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  41. Published

    Glucagon-like peptide-1, glucose homeostasis and diabetes.

    Holst, Jens Juul, Deacon, Carolyn F., Vilsbøll, Tina, Krarup, T. & Madsbad, Sten, 2008, In: Trends in Molecular Medicine. 14, 4, p. 161-8 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  42. Published

    Replacing SUs with incretin-based therapies for type 2 diabetes mellitus: Challenges and feasibility

    Knop, F. K., Holst, Jens Juul & Vilsbøll, Tina, 2008, In: IDrugs. The Investigational Drugs Journal. 11, 7, p. 497-501 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  43. Published

    The incretin system and its role in type 2 diabetes mellitus

    Holst, Jens Juul, Vilsbøll, Tina & Deacon, Carolyn F., 2008, In: Molecular and Cellular Endocrinology. 297, 1-2, p. 127-136 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  44. Published

    Long-acting GLP-1 analogs for the treatment of type 2 diabetes mellitus

    Vilsbøll, Tina & Knop, Filip Krag, 1 Jan 2008, In: BioDrugs. 22, 4, p. 251-7 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  45. Published

    Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus

    Vilsbøll, Tina, Brock, B., Perrild, H., Levin, K., Lervang, H., Kølendorf, K. E., Krarup, T., Schmitz, O., Zdravkovic, M., Le Thi Thanh, X. & Madsbad, Sten, 1 Feb 2008, In: Diabetic Medicine. 25, 2, p. 152-6 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  46. Published

    Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide

    Horowitz, M., Vilsbøll, Tina, Zdravkovic, M., Hammer, M. & Madsbad, Sten, 1 Jul 2008, In: Diabetes, Obesity and Metabolism. 10, 7, p. 593-6 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  47. Published

    Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes

    Courrèges, J., Vilsbøll, Tina, Zdravkovic, M., Le Thi Thanh, X., Krarup, T., Schmitz, O., Verhoeven, R., Bugáñová, I. & Madsbad, Sten, 1 Sep 2008, In: Diabetic Medicine. 25, 9, p. 1129-31 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  48. Published

    Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes

    Højberg, P. V., Vilsbøll, Tina, Zander, P. M., Knop, Filip Krag, Krarup, T., Vølund, A., Holst, J. M. & Madsbad, Sten, 1 Nov 2008, In: Diabetic Medicine. 25, 11, p. 1268-75 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  49. 2009
  50. Published

    Glucagon-like peptide-1 and diabetes treatment

    Vilsbøll, Tina, Hare, K., Bagger, J. O. & Knop, Filip Krag, 2009, In: International Diabetes Monitor. 21, p. 1-7 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  51. Published

    Incretin hormones and diabetes mellitus

    Vilsbøll, Tina, Knop, Filip Krag, Deacon, Carolyn F. & Holst, Jens Juul, 2009, Therapeutic Strategies in Diabetes. Stehouwer, C. D. A. & Schaper, N. (eds.). Oxford: Clinical Publishing, p. 99-114

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  52. Published

    Incretin-based therapy of type 2 diabetes mellitus

    Knop, Filip Krag, Vilsbøll, Tina & Holst, Jens Juul, 2009, In: Current Protein and Peptide Science. 10, 1, p. 46-55 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  53. Published

    Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings?

    Giugliano, D., Standl, E., Vilsbøll, Tina, Betteridge, J., Bonadonna, R., Campbell, I. W., Schernthaner, G., Staels, B., Trichopoulou, A. & Farinaro, E., 2009, In: Acta Diabetologica. 46, 3, p. 173-81 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  54. Published

    KATP channel closure ameliorates the impaired insulinotropic effect of glucose-dependent insulinotropic polypeptide (GIP) in patients with type 2 diabetes

    Aaboe, K., Knop, Filip Krag, Vilsbøll, Tina, Vølund, A., Simonsen, U., Deacon, Carolyn F., Madsbad, Sten, Holst, Jens Juul & Krarup, T., 2009, In: Journal of Clinical Endocrinology and Metabolism. 94, 2, p. 603-608

    Research output: Contribution to journalJournal articleResearchpeer-review

  55. Published

    Liraglutide: a human GLP-1 analog for Type 2 diabetes

    Vilsbøll, Tina, 2009, In: Therapy. 6, 2, p. 199-207 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  56. Published

    Liraglutide: a new treatment for type 2 diabetes

    Vilsbøll, Tina, 2009, In: Drugs of Today. 45, 2, p. 101-13 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  57. Published

    Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitus

    Hare, K. J., Knop, Filip Krag, Asmar, M., Madsbad, Sten, Deacon, Carolyn F., Holst, Jens Juul & Vilsbøll, Tina, 2009, In: Journal of Clinical Endocrinology and Metabolism. 94, 12, p. 4679-87 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  58. Published

    The effects of glucagon-like peptide-1 on the beta cell

    Vilsbøll, Tina, 2009, In: Diabetes, Obesity and Metabolism. 11 Suppl 3, p. 11-18 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  59. Published

    The spectrum of antidiabetic actions of GLP-1 in patients with diabetes

    Vilsbøll, Tina, Holst, Jens Juul & Knop, Filip Krag, 2009, In: Best Practice & Research: Clinical Endocrinology & Metabolism. 23, 4, p. 453-62 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  60. Published

    Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists

    Hansen, K. B., Knop, Filip Krag, Holst, Jens Juul & Vilsbøll, Tina, 2009, In: International Journal of Clinical Practice. 63, 8, p. 1154-60 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  61. Published

    Twelve weeks treatment with the DPP-4 inhibitor sitagliptin improves glycaemic control, but does not improve GLP-1 secretion, in patients with type 2 diabetes - a randomised trial

    Aaboe, K., Knop, F. K., Vilsbøll, Tina, Deacon, Carolyn F., Holst, Jens Juul, Madsbad, Sten & Krarup, T., 2009, In: Diabetologia. p. 748

    Research output: Contribution to journalConference abstract in journalResearch

  62. Published

    The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men

    Pilgaard, K., Jensen, C., Schou, J., Lyssenko, V., Wegner, L., Brøns, C., Vilsbøll, T., Hansen, T., Madsbad, S., Holst, J., Vølund, A., Poulsen, P., Groop, L., Pedersen, O., Vaag, A., Pilgaard, K., Jensen, C. B., Schou, J. H., Lyssenko, V., Wegner, L. & 10 others, Brøns, C., Vilsbøll, T., Hansen, T., Madsbad, Sten, Holst, J. M., Vølund, A., Poulsen, P., Groop, L., Pedersen, O. & Vaag, A., 1 Jul 2009, In: Diabetologia. 52, 7, p. 1298-307 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 9 Next

ID: 33056950